SAG
PFE icon

Susquehanna Advisors Group’s Pfizer PFE Stock Holding History

Susquehanna Advisors Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$140M Sell
5,000,000
-1,800,000
-26% -$47.9M 4.61% 2
2025
Q4 		$169M Buy
6,800,000
+1,800,000
+36% +$45.4M 2.81% 12
2025
Q3 		$127M Buy
5,000,000
+870,000
+21% +$21.5M 1.95% 17
2025
Q2 		$100M Buy
+4,130,000
New +$96.3M 2.71% 8
2025
Q1 		– Sell
-3,500,000
Closed -$92.9M – 122
2024
Q4 		$92.9M Buy
+3,500,000
New +$94.9M 2.71% 9

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Susquehanna Advisors Group's PFE Position: Q1 2026 in Review

Susquehanna Advisors Group reduced its Pfizer (PFE) stake by 26% in Q1 2026, selling an estimated $47.9M and leaving 5,000,000 shares worth $140M. The position accounts for 4.61% of the portfolio, ranked #2.

Susquehanna Advisors Group first reported a position in PFE in Q4 2024 and has held it in 5 quarters since. The position peaked at $169M in Q4 2025. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Susquehanna Advisors Group held 5,000,000 shares of Pfizer worth $140M as of Q1 2026.
  • Susquehanna Advisors Group sold 1,800,000 Pfizer shares in Q1 2026, an estimated $47.9M.
  • Pfizer made up 4.61% of Susquehanna Advisors Group's portfolio in Q1 2026, its #2 holding.
  • Susquehanna Advisors Group first reported a position in Pfizer in Q4 2024 and has held it in 5 quarters since.
  • Susquehanna Advisors Group's Pfizer position peaked at $169M in Q4 2025.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Susquehanna Advisors Group's 13F filing for Q1 2026, filed 15 May 2026.